How rock-bottom prices drive shortages of generic drugs used in hospitals
Rena Conti, TPRI Faculty Director, quoted in NPR, December 28, 2023.
Category: All Articles
Digitalization is not gender-neutral
By Sabrina Genz and Claus Schnabel
Although numerous studies have investigated the aggregate employment effects of automation and digitalization, relatively little is known about the effects at the level of individual workers and along the gender dimension.
AI and the workforce
James Bessen, TPRI Executive Director, provided testimony before the House of Commons of Canada HUMA Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities about AI and the workforce on November 20, 2023.
What history tells us to expect about the future of AI and automation
James Bessen, TPRI Executive Director, was interviewed and his research was cited in “What history tells us to expect about the future of AI and automation”, Charter Works, November 12, 2023.
Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot
Marta Wosińska and Rena Conti, TPRI Faculty Director, article
“Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot” Brookings Institution, November 1, 2023.
The estimated annual financial impact of gene therapy in the United States
By Chi Heem Wong, Dexin Li, Nina Wang, Jonathan Gruber, Andrew W. Lo & Rena M. Conti
Gene therapy is a new class of medical treatment that alters part of a patient’s genome through the replacement, deletion, or insertion of genetic material.
Financial Stress Can Squeeze the ‘R’ Out of R&D
Filippo Mezzanotti and Timothy Simcoe’s research discussed in NBER Digest, October 10, 2023
Why Massachusetts companies should include salary ranges in job postings
TPRI’s research study cited in Boston Globe, October 8, 2023
People are underestimating the significance of drug pricing provisions in Inflation Reduction Act
Rena Conti, Leslie Dach and Richard Frank, Opinion Article The Hill, October 6, 2023.
Bipartisan battle over prescription intermediaries heats up
Rena Conti, TPRI Faculty Director, quoted in The Hill, 09/28/23